
Willis Towers WatsonWTW
Quality and valuation
How Willis Towers Watson compares with other financials stocks. A description, not a recommendation.
MRSH
AJG
AON
BRO
ERIE
WTWWillis Towers Watson and 5 insurance brokers peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.
A weaker business than most financials companies, priced about in line with them.
Willis Towers Watson trades at 15.5 times the next 12 months of expected earnings, against a median of 13.0x for the 84 financials stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.
- Revenue grew slower than the sector median: +4.8% vs +10.2%
- Less profitable (operating margin): 22.0% vs 22.3%
- Turns less of its sales into cash: 17.0% vs 20.3%
Financials
From Willis Towers Watson's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.
| Last 12 months | WTW | Sector median |
|---|---|---|
| Revenue growth | +4.8% | +10.2% |
| Operating margin | 22.0% | 22.3% |
| Free cash flow margin | 17.0% | 20.3% |
| Price to earnings | 19.8x | 14.6x |
Stories on Willis Towers Watson
We haven't written about Willis Towers Watson yet. Follow it, and its first story will show under My stocks on the front page.
Similar companies
Insurance Brokers, by market value.
| Company | Price | Today |
|---|---|---|
MRSHMarsh McLennan | $200.62 | +1.82% |
AJGArthur J. Gallagher | $276.07 | +2.93% |
AONAon | $321.67 | +0.01% |
BROBrown & Brown | $69.76 | +2.83% |
ERIEErie Indemnity | $261.39 | +4.23% |